<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Mesa Laboratories Inc — News on 6ix</title>
    <link>https://6ix.com/company/mesa-laboratories-inc</link>
    <description>Latest news and press releases for Mesa Laboratories Inc on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Mon, 09 Mar 2026 04:00:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/mesa-laboratories-inc" rel="self" type="application/rss+xml" />
    <image>
      <url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo68359a2178dffbe2df1062a0.webp</url>
      <title>Mesa Laboratories Inc</title>
      <link>https://6ix.com/company/mesa-laboratories-inc</link>
    </image>
    <item>
      <title>Mesa Laboratories Announces CEO Transition and Appointment of Siddhartha Kadia as President and CEO</title>
      <link>https://6ix.com/company/mesa-laboratories-inc/news/mesa-laboratories-announces-ceo-transition-and-appointment-of-siddhartha-kadia-as-president-and-ceo</link>
      <guid isPermaLink="true">https://6ix.com/company/mesa-laboratories-inc/news/mesa-laboratories-announces-ceo-transition-and-appointment-of-siddhartha-kadia-as-president-and-ceo</guid>
      <pubDate>Mon, 09 Mar 2026 04:00:00 GMT</pubDate>
      <description>LAKEWOOD, Colo., March 09, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ: MLAB) (“Mesa” or “the Company”), a global leader in the design and</description>
    </item>
    <item>
      <title>As Worker Safety Scrutiny Intensifies, Mesa Labs Reinforces Why Primary Standard Calibration Is the Only Line of Defense</title>
      <link>https://6ix.com/company/mesa-laboratories-inc/news/as-worker-safety-scrutiny-intensifies-mesa-labs-reinforces-why-primary-standard-calibration-is-the-only-line-of-defense</link>
      <guid isPermaLink="true">https://6ix.com/company/mesa-laboratories-inc/news/as-worker-safety-scrutiny-intensifies-mesa-labs-reinforces-why-primary-standard-calibration-is-the-only-line-of-defense</guid>
      <pubDate>Wed, 18 Feb 2026 14:00:00 GMT</pubDate>
      <description>OSHA standardizes on Mesa’s DryCal Defender technology for field enforcement as industry faces generational knowledge gap in flow calibrationLAKEWOOD, Colo., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ: MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced a renewed commitment to advancing primary standard calibration technology through its DryCal product line, as occupational health and safety pro</description>
    </item>
    <item>
      <title>Mesa Labs Announces Third Quarter Results</title>
      <link>https://6ix.com/company/mesa-laboratories-inc/news/mesa-labs-announces-third-quarter-130000618</link>
      <guid isPermaLink="true">https://6ix.com/company/mesa-laboratories-inc/news/mesa-labs-announces-third-quarter-130000618</guid>
      <pubDate>Tue, 03 Feb 2026 13:00:00 GMT</pubDate>
      <description>LAKEWOOD, Colo., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (“Mesa” or “the Company”), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for its third fiscal quarter (“3Q26”) ended December 31, 2025 (amounts in thousands). 3Q26 Financial Summary – (comparisons are versus the same year ago period Revenues increased 3.6%Non-GAAP organic and core organic revenues1 growth was 3.6% and 1.2%,</description>
    </item>
    <item>
      <title>MESA LABS DECLARES QUARTERLY DIVIDEND</title>
      <link>https://6ix.com/company/mesa-laboratories-inc/news/mesa-labs-declares-quarterly-dividend-220000617</link>
      <guid isPermaLink="true">https://6ix.com/company/mesa-laboratories-inc/news/mesa-labs-declares-quarterly-dividend-220000617</guid>
      <pubDate>Wed, 07 Jan 2026 22:00:00 GMT</pubDate>
      <description>LAKEWOOD, Colo., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on March 16, 2026, to shareholders of record at the close of business on February 28, 2026. About Mesa Laboratories, Inc. Mesa is a global leader in the design and manufacture of life science tools and critical quality co</description>
    </item>
    <item>
      <title>Mesa Labs to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026</title>
      <link>https://6ix.com/company/mesa-laboratories-inc/news/mesa-labs-present-44th-annual-000000471</link>
      <guid isPermaLink="true">https://6ix.com/company/mesa-laboratories-inc/news/mesa-labs-present-44th-annual-000000471</guid>
      <pubDate>Fri, 19 Dec 2025 00:00:00 GMT</pubDate>
      <description>LAKEWOOD, Colo., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced that Gary Owens, President and CEO, and John Sakys, CFO will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14th, 2026. Management will participate in a Formal Presentation at 4:30 p.m. Pacific Time. A live webcast of the presentation will be accessi</description>
    </item>
    <item>
      <title>Mesa Laboratories, Inc. to Participate in Upcoming Investor Conferences</title>
      <link>https://6ix.com/company/mesa-laboratories-inc/news/mesa-laboratories-inc-participate-upcoming-201400907</link>
      <guid isPermaLink="true">https://6ix.com/company/mesa-laboratories-inc/news/mesa-laboratories-inc-participate-upcoming-201400907</guid>
      <pubDate>Wed, 12 Nov 2025 20:14:00 GMT</pubDate>
      <description>LAKEWOOD, Colo., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced that Gary Owens, President and CEO, and John Sakys, CFO will be attending the following upcoming conferences: Raymond James Napa Valley Small Cap SymposiumFormat: 1x1 Meetings Date: Monday, November 17, 2025Jefferies London Healthcare Conference Format: Fireside chatDate: Thursday, November 20, 2025Time: 12:00 p.m. GMTWebcast: Click Here 8th Annual Evercore Healthcare ConferenceFormat: Firesi</description>
    </item>
    <item>
      <title>Mesa Labs Announces Second Quarter Results</title>
      <link>https://6ix.com/company/mesa-laboratories-inc/news/mesa-labs-announces-second-quarter-211500731</link>
      <guid isPermaLink="true">https://6ix.com/company/mesa-laboratories-inc/news/mesa-labs-announces-second-quarter-211500731</guid>
      <pubDate>Thu, 06 Nov 2025 21:15:00 GMT</pubDate>
      <description>LAKEWOOD, Colo., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (“Mesa” or “the Company”), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for its second fiscal quarter (“2Q26”) ended September 30, 2025 (amounts in thousands). Financial Summary – 2Q26 versus the same year ago period Revenues increased 5.0%Non-GAAP core organic revenues1 growth was 3.7%Operating income increased 34.7% to $</description>
    </item>
    <item>
      <title>Mesa Laboratories Executes Previously-Announced Strategic Financing Plan</title>
      <link>https://6ix.com/company/mesa-laboratories-inc/news/mesa-laboratories-executes-previously-announced-180100463</link>
      <guid isPermaLink="true">https://6ix.com/company/mesa-laboratories-inc/news/mesa-laboratories-executes-previously-announced-180100463</guid>
      <pubDate>Mon, 18 Aug 2025 18:01:00 GMT</pubDate>
      <description>LAKEWOOD, Colo., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ: MLAB) (we, us, our, “Mesa” or the “Company”) today announced that it has executed on its previously-announced financial strategy, repaying $97.5 million aggregate principal of the Company’s 1.375% Convertible Senior Notes due August 2025 (the “2025 Notes”). On August 12, 2025, the Company drew $97.0 million under its existing Amended and Restated Credit Agreement (the “Credit Agreement”), bringing the total outst</description>
    </item>
    <item>
      <title>Mesa Labs Announces First Quarter Results</title>
      <link>https://6ix.com/company/mesa-laboratories-inc/news/mesa-labs-announces-first-quarter-120000392</link>
      <guid isPermaLink="true">https://6ix.com/company/mesa-laboratories-inc/news/mesa-labs-announces-first-quarter-120000392</guid>
      <pubDate>Tue, 05 Aug 2025 12:00:00 GMT</pubDate>
      <description>LAKEWOOD, Colo., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for its first fiscal quarter (“1Q26”) ended June 30, 2025 (amounts in thousands). First quarter FY26 compared to first quarter FY25: Revenues increased 2.4%Non-GAAP core organic revenues1 growth was 0.4% Operating income decreased 45.1% to $3,064 primarily due to the impacts of</description>
    </item>
    <item>
      <title>Mesa Labs Announces Fourth Quarter and Full Fiscal Year 2025 Results</title>
      <link>https://6ix.com/company/mesa-laboratories-inc/news/mesa-labs-announces-fourth-quarter-120000971</link>
      <guid isPermaLink="true">https://6ix.com/company/mesa-laboratories-inc/news/mesa-labs-announces-fourth-quarter-120000971</guid>
      <pubDate>Wed, 28 May 2025 12:00:00 GMT</pubDate>
      <description>LAKEWOOD, Colo., May 28, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for its fourth fiscal quarter (“4Q25”) and full fiscal year (“FY25”) ended March 31, 2025 (amounts in thousands). Fourth quarter FY25 compared to fourth quarter FY24: Revenues increased 5.5%Non-GAAP core organic revenues growth1 was 6.3%Operating income increased 100.5% to $1,46</description>
    </item>
    <item>
      <title>Mesa Labs Announces Fourth Quarter and Full Fiscal Year 2024 Results</title>
      <link>https://6ix.com/company/mesa-laboratories-inc/news/mesa-labs-announces-fourth-quarter-and-full-fiscal-year-2024-results</link>
      <guid isPermaLink="true">https://6ix.com/company/mesa-laboratories-inc/news/mesa-labs-announces-fourth-quarter-and-full-fiscal-year-2024-results</guid>
      <pubDate>Wed, 05 Jun 2024 04:00:00 GMT</pubDate>
      <description>LAKEWOOD, Colo., June 05, 2024 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools</description>
    </item>
    <item>
      <title>Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results</title>
      <link>https://6ix.com/company/mesa-laboratories-inc/news/mesa-laboratories-inc-revises-earnings-announcement-date-for-unaudited-fourth-quarter-and-full-fiscal-year-2024-results</link>
      <guid isPermaLink="true">https://6ix.com/company/mesa-laboratories-inc/news/mesa-laboratories-inc-revises-earnings-announcement-date-for-unaudited-fourth-quarter-and-full-fiscal-year-2024-results</guid>
      <pubDate>Fri, 31 May 2024 04:00:00 GMT</pubDate>
      <description>LAKEWOOD, Colo., May 31, 2024 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (“Mesa”) (NASDAQ:MLAB) will not issue its 2024 financial results for the fourth</description>
    </item>
    <item>
      <title>Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results to May 31, 2024</title>
      <link>https://6ix.com/company/mesa-laboratories-inc/news/mesa-laboratories-inc-revises-earnings-announcement-date-for-unaudited-fourth-quarter-and-full-fiscal-year-2024-results-to-may-31-2024</link>
      <guid isPermaLink="true">https://6ix.com/company/mesa-laboratories-inc/news/mesa-laboratories-inc-revises-earnings-announcement-date-for-unaudited-fourth-quarter-and-full-fiscal-year-2024-results-to-may-31-2024</guid>
      <pubDate>Wed, 22 May 2024 04:00:00 GMT</pubDate>
      <description>LAKEWOOD, Colo., May 22, 2024 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (“Mesa”) (NASDAQ:MLAB) will issue a press release with financial results for the</description>
    </item>
    <item>
      <title>MESA LABS ANNOUNCES AMENDMENT TO CREDIT FACILITY AND REPURCHASE OF SENIOR CONVERTIBLE NOTES</title>
      <link>https://6ix.com/company/mesa-laboratories-inc/news/mesa-labs-announces-amendment-to-credit-facility-and-repurchase-of-senior-convertible-notes</link>
      <guid isPermaLink="true">https://6ix.com/company/mesa-laboratories-inc/news/mesa-labs-announces-amendment-to-credit-facility-and-repurchase-of-senior-convertible-notes</guid>
      <pubDate>Mon, 08 Apr 2024 04:00:00 GMT</pubDate>
      <description>Lakewood, Colo., April 08, 2024 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced the closing</description>
    </item>
    <item>
      <title>Mesa Labs Releases Second Annual Responsible Business Program Brochure</title>
      <link>https://6ix.com/company/mesa-laboratories-inc/news/mesa-labs-releases-second-annual-responsible-business-program-brochure</link>
      <guid isPermaLink="true">https://6ix.com/company/mesa-laboratories-inc/news/mesa-labs-releases-second-annual-responsible-business-program-brochure</guid>
      <pubDate>Fri, 15 Mar 2024 04:00:00 GMT</pubDate>
      <description>LAKEWOOD, Colo, March 15, 2024 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB, “Mesa” “we” “our” or the “Company”), a global leader in the design</description>
    </item>
    <item>
      <title>Mesa Laboratories Appoints Mark Capone to its Board of Directors</title>
      <link>https://6ix.com/company/mesa-laboratories-inc/news/mesa-laboratories-appoints-mark-capone-to-its-board-of-directors</link>
      <guid isPermaLink="true">https://6ix.com/company/mesa-laboratories-inc/news/mesa-laboratories-appoints-mark-capone-to-its-board-of-directors</guid>
      <pubDate>Mon, 08 Jan 2024 05:00:00 GMT</pubDate>
      <description>LAKEWOOD, Colo., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (“Mesa”, “we”, “us”, or “our”), a global leader in the design and</description>
    </item>
    <item>
      <title>Mesa Labs Completes the Acquisition of GKE Science &amp; Technology Co.</title>
      <link>https://6ix.com/company/mesa-laboratories-inc/news/mesa-labs-completes-the-acquisition-of-gke-science-and-technology-co</link>
      <guid isPermaLink="true">https://6ix.com/company/mesa-laboratories-inc/news/mesa-labs-completes-the-acquisition-of-gke-science-and-technology-co</guid>
      <pubDate>Wed, 03 Jan 2024 05:00:00 GMT</pubDate>
      <description>LAKEWOOD, Colo., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (“Mesa”, “we”, “us” or “our”), a global leader in the design and</description>
    </item>
    <item>
      <title>Mesa Laboratories, Inc. to Announce Second Quarter Results on February 5, 2024</title>
      <link>https://6ix.com/company/mesa-laboratories-inc/news/mesa-laboratories-inc-to-announce-second-quarter-results-on-february-5-2024</link>
      <guid isPermaLink="true">https://6ix.com/company/mesa-laboratories-inc/news/mesa-laboratories-inc-to-announce-second-quarter-results-on-february-5-2024</guid>
      <pubDate>Thu, 14 Dec 2023 05:00:00 GMT</pubDate>
      <description>LAKEWOOD, Colo., Dec. 14, 2023 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the third</description>
    </item>
    <item>
      <title>Mesa Labs Acquires GKE-GmbH Complementary Sterilization Indicators and Healthcare Channels to Mesa’s SDC Platform</title>
      <link>https://6ix.com/company/mesa-laboratories-inc/news/mesa-labs-acquires-gke-gmbh-complementary-sterilization-indicators-and-healthcare-channels-to-mesas-sdc-platform</link>
      <guid isPermaLink="true">https://6ix.com/company/mesa-laboratories-inc/news/mesa-labs-acquires-gke-gmbh-complementary-sterilization-indicators-and-healthcare-channels-to-mesas-sdc-platform</guid>
      <pubDate>Mon, 16 Oct 2023 04:00:00 GMT</pubDate>
      <description>Lakewood, Colo., Oct. 16, 2023 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (“Mesa”, “we”, “us” or “our”), a global leader in the design and</description>
    </item>
    <item>
      <title>Mesa Laboratories, Inc. Announces Commitment to Disclose Scope 1 and 2 Greenhouse Gas Emissions</title>
      <link>https://6ix.com/company/mesa-laboratories-inc/news/mesa-laboratories-inc-announces-commitment-to-disclose-scope-1-and-2-greenhouse-gas-emissions</link>
      <guid isPermaLink="true">https://6ix.com/company/mesa-laboratories-inc/news/mesa-laboratories-inc-announces-commitment-to-disclose-scope-1-and-2-greenhouse-gas-emissions</guid>
      <pubDate>Thu, 24 Aug 2023 04:00:00 GMT</pubDate>
      <description>LAKEWOOD, Colo., Aug. 24, 2023 (GLOBE NEWSWIRE) -- Mesa Laboratories Inc (Nasdaq: MLAB; “Mesa” or the “Company”), a global leader in the design and</description>
    </item>
  </channel>
</rss>